Lista de obras -

A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis.

artículo científico publicado en 2013

AL amyloidosis patients with low amyloidogenic free light chain levels at first diagnosis have an excellent prognosis.

artículo científico publicado en 2017

Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning

artículo científico publicado en 2003

Allogeneic and syngeneic hematopoietic cell transplantation in patients with amyloid light-chain amyloidosis: a report from the European Group for Blood and Marrow Transplantation.

artículo científico publicado en 2005

Allografting after nonmyeloablative conditioning as a treatment after a failed conventional hematopoietic cell transplant ⬇️

artículo científico publicado el 1 de abril de 2003

Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma

artículo científico publicado en 2003

Anterior Aortic Plane Systolic Excursion: A Novel Indicator of Transplant-Free Survival in Systemic Light-Chain Amyloidosis.

artículo científico publicado en 2016

Assessment of disease severity and outcome in patients with systemic light-chain amyloidosis by the high-sensitivity troponin T assay

artículo científico publicado en 2010

Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study.

artículo científico publicado en 2013

Bone involvement in patients with systemic AL amyloidosis mimics lytic myeloma bone disease

scientific article published on 01 June 2008

Comparison of Different Stem Cell Mobilization Regimens in AL Amyloidosis Patients

artículo científico publicado en 2017

Cryo-EM structure of a light chain-derived amyloid fibril from a patient with systemic AL amyloidosis

artículo científico publicado en 2019

Diagnostic work up of an adult female patient with systemic AA amyloidosis revealing the cause of infantile mental retardation.

artículo científico publicado en 2017

Efficacy and tolerability of the histone deacetylase inhibitor panobinostat in clinical practice.

artículo científico publicado en 2017

Eight novel loci implicate shared genetic etiology in multiple myeloma, AL amyloidosis, and monoclonal gammopathy of unknown significance

artículo científico publicado en 2019

European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias

artículo científico publicado en 2018

Evaluation of the clinical use of midregional pro-atrial natriuretic peptide (MR-proANP) in comparison to N-terminal pro-B-type natriuretic peptide (NT-proBNP) for risk stratification in patients with light-chain amyloidosis

artículo científico publicado en 2014

Evaluation of the cytogenetic aberration pattern in amyloid light chain amyloidosis as compared with monoclonal gammopathy of undetermined significance reveals common pathways of karyotypic instability

artículo científico publicado en 2008

Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis.

artículo científico publicado en 2008

First report of ibrutinib in IgM-related amyloidosis: few responses, poor tolerability, and short survival

artículo científico publicado en 2017

Flow cytometry-based characterization of underlying clonal B and plasma cells in patients with light chain amyloidosis

artículo científico publicado en 2016

Gain of chromosome 1q21 is an independent adverse prognostic factor in light chain amyloidosis patients treated with melphalan/dexamethasone

article by Tilmann Bochtler et al published 23 January 2014 in Amyloid

Genome-wide association study of clinical parameters in immunoglobulin light chain amyloidosis in three patient cohorts.

artículo científico publicado en 2017

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

artículo científico publicado en 2003

Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia

artículo científico publicado en 2005

Humoral Responses and Chronic GVHD Exacerbation after COVID-19 Vaccination Post Allogeneic Stem Cell Transplantation

artículo científico publicado en 2022

Hyperdiploidy is less frequent in AL amyloidosis compared with monoclonal gammopathy of undetermined significance and inversely associated with translocation t(11;14).

artículo científico publicado en 2011

Indications for high-dose chemotherapy with autologous stem cell support in patients with systemic amyloid light chain amyloidosis

artículo científico publicado en 2005

Indications for liver transplantation in patients with amyloidosis: a single-center experience with 11 cases.

artículo científico publicado en 2005

Initial experience with percutaneous mitral valve repair in patients with cardiac amyloidosis

scientific article published on 16 December 2020

Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis: results of a prospective phase 2 study with long-term follow up.

artículo científico

Long-term efficacy of reduced-intensity versus myeloablative conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: retrospective follow-up of an open-label, randomised

artículo científico publicado en 2018

Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers

artículo científico publicado en 2012

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induc

artículo científico publicado en 2002

Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group

artículo científico publicado en 2008

Myocardial contraction fraction derived from cardiovascular magnetic resonance cine images-reference values and performance in patients with heart failure and left ventricular hypertrophy

artículo científico publicado en 2017

New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes

artículo científico publicado en 2012

Non-invasive predictors of survival in cardiac amyloidosis

scientific article published on 09 March 2007

Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission

artículo científico publicado en 2003

Novel recurrent chromosomal aberrations detected in clonal plasma cells of light chain amyloidosis patients show potential adverse prognostic effect: first results from a genome-wide copy number array analysis

artículo científico publicado en 2017

Outcome of high-risk acute myeloid leukemia after allogeneic hematopoietic cell transplantation: negative impact of abnl(17p) and -5/5q-.

artículo científico publicado en 2012

Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

artículo científico publicado en 2014

Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma

artículo científico publicado en 2007

Potential therapeutic targets in plasma cell disorders: A flow cytometry study.

artículo científico publicado en 2015

Pre-transplant weight loss predicts inferior outcome after allogeneic stem cell transplantation in patients with myelodysplastic syndrome

artículo científico publicado en 2015

Pretransplant metabolic distress predicts relapse of acute myeloid leukemia after allogeneic stem cell transplantation

artículo científico publicado en 2015

Prognostic impact of cytogenetic aberrations in AL amyloidosis patients after high-dose melphalan: a long-term follow-up study

artículo científico publicado en 2016

Prognostic relevance of 'early-onset' graft-versus-host disease following non-myeloablative haematopoietic cell transplantation

artículo científico publicado en 2005

Prognostic significance of semiautomatic quantification of left ventricular long axis shortening in systemic light-chain amyloidosis.

artículo científico publicado en 2014

Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death.

artículo científico publicado en 2007

Rapid assessment of longitudinal systolic left ventricular function using speckle tracking of the mitral annulus

artículo científico publicado en 2011

Rapid progression of left ventricular wall thickness predicts mortality in cardiac light-chain amyloidosis

artículo científico publicado en 2007

Real-world outcomes in non-endemic hereditary transthyretin amyloidosis with polyneuropathy: a 20-year German single-referral centre experience

scientific article published on 07 December 2020

Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial.

artículo científico publicado en 2012

Regional differences in prognostic value of cardiac valve plane displacement in systemic light-chain amyloidosis

artículo científico publicado en 2017

Related and unrelated nonmyeloablative hematopoietic stem cell transplantation for malignant diseases

artículo científico publicado en 2002

Reply to S. Girnius et al.

artículo científico publicado en 2013

Respiratory muscle weakness and inefficient ventilation in heart failure due to light-chain amyloidosis

Risk stratification in cardiac amyloidosis: novel approaches

artículo científico publicado en 2005

Skeletal scintigraphy indicates disease severity of cardiac involvement in patients with senile systemic amyloidosis

artículo científico publicado en 2011

Staged heart transplantation and chemotherapy as a treatment option in patients with severe cardiac light-chain amyloidosis

artículo científico publicado en 2009

The impact of allogeneic hematopoietic cell transplantation on the mortality of poor-risk non-Hodgkin lymphoma: an intent-to-transplant analysis

scientific article published on 18 June 2020

Translocation t(11;14) is associated with adverse outcome in patients with newly diagnosed AL amyloidosis when treated with bortezomib-based regimens

artículo científico publicado en 2015

Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors

artículo científico publicado en 2005

Treatment with intravenous melphalan and dexamethasone is not able to overcome the poor prognosis of patients with newly diagnosed systemic light chain amyloidosis and severe cardiac involvement

artículo científico publicado en 2010

Lista de obras de

A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis.

AL amyloidosis patients with low amyloidogenic free light chain levels at first diagnosis have an excellent prognosis.

Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning

Allogeneic and syngeneic hematopoietic cell transplantation in patients with amyloid light-chain amyloidosis: a report from the European Group for Blood and Marrow Transplantation.

Allografting after nonmyeloablative conditioning as a treatment after a failed conventional hematopoietic cell transplant ⬇️

Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma

Anterior Aortic Plane Systolic Excursion: A Novel Indicator of Transplant-Free Survival in Systemic Light-Chain Amyloidosis.

Assessment of disease severity and outcome in patients with systemic light-chain amyloidosis by the high-sensitivity troponin T assay

Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study.

Bone involvement in patients with systemic AL amyloidosis mimics lytic myeloma bone disease

Comparison of Different Stem Cell Mobilization Regimens in AL Amyloidosis Patients

Cryo-EM structure of a light chain-derived amyloid fibril from a patient with systemic AL amyloidosis

Diagnostic work up of an adult female patient with systemic AA amyloidosis revealing the cause of infantile mental retardation.

Efficacy and tolerability of the histone deacetylase inhibitor panobinostat in clinical practice.

Eight novel loci implicate shared genetic etiology in multiple myeloma, AL amyloidosis, and monoclonal gammopathy of unknown significance

European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias

Evaluation of the clinical use of midregional pro-atrial natriuretic peptide (MR-proANP) in comparison to N-terminal pro-B-type natriuretic peptide (NT-proBNP) for risk stratification in patients with light-chain amyloidosis

Evaluation of the cytogenetic aberration pattern in amyloid light chain amyloidosis as compared with monoclonal gammopathy of undetermined significance reveals common pathways of karyotypic instability

Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis.

First report of ibrutinib in IgM-related amyloidosis: few responses, poor tolerability, and short survival

Flow cytometry-based characterization of underlying clonal B and plasma cells in patients with light chain amyloidosis

Gain of chromosome 1q21 is an independent adverse prognostic factor in light chain amyloidosis patients treated with melphalan/dexamethasone

Genome-wide association study of clinical parameters in immunoglobulin light chain amyloidosis in three patient cohorts.

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia

Humoral Responses and Chronic GVHD Exacerbation after COVID-19 Vaccination Post Allogeneic Stem Cell Transplantation

Hyperdiploidy is less frequent in AL amyloidosis compared with monoclonal gammopathy of undetermined significance and inversely associated with translocation t(11;14).

Indications for high-dose chemotherapy with autologous stem cell support in patients with systemic amyloid light chain amyloidosis

Indications for liver transplantation in patients with amyloidosis: a single-center experience with 11 cases.

Initial experience with percutaneous mitral valve repair in patients with cardiac amyloidosis

Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis: results of a prospective phase 2 study with long-term follow up.

Long-term efficacy of reduced-intensity versus myeloablative conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: retrospective follow-up of an open-label, randomised

Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induc

Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group

Myocardial contraction fraction derived from cardiovascular magnetic resonance cine images-reference values and performance in patients with heart failure and left ventricular hypertrophy

New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes

Non-invasive predictors of survival in cardiac amyloidosis

Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission

Novel recurrent chromosomal aberrations detected in clonal plasma cells of light chain amyloidosis patients show potential adverse prognostic effect: first results from a genome-wide copy number array analysis

Outcome of high-risk acute myeloid leukemia after allogeneic hematopoietic cell transplantation: negative impact of abnl(17p) and -5/5q-.

Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma

Potential therapeutic targets in plasma cell disorders: A flow cytometry study.

Pre-transplant weight loss predicts inferior outcome after allogeneic stem cell transplantation in patients with myelodysplastic syndrome

Pretransplant metabolic distress predicts relapse of acute myeloid leukemia after allogeneic stem cell transplantation

Prognostic impact of cytogenetic aberrations in AL amyloidosis patients after high-dose melphalan: a long-term follow-up study

Prognostic relevance of 'early-onset' graft-versus-host disease following non-myeloablative haematopoietic cell transplantation

Prognostic significance of semiautomatic quantification of left ventricular long axis shortening in systemic light-chain amyloidosis.

Prophylactic implantation of cardioverter-defibrillator in patients with severe cardiac amyloidosis and high risk for sudden cardiac death.

Rapid assessment of longitudinal systolic left ventricular function using speckle tracking of the mitral annulus

Rapid progression of left ventricular wall thickness predicts mortality in cardiac light-chain amyloidosis

Real-world outcomes in non-endemic hereditary transthyretin amyloidosis with polyneuropathy: a 20-year German single-referral centre experience

Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial.

Regional differences in prognostic value of cardiac valve plane displacement in systemic light-chain amyloidosis

Related and unrelated nonmyeloablative hematopoietic stem cell transplantation for malignant diseases

Reply to S. Girnius et al.

Respiratory muscle weakness and inefficient ventilation in heart failure due to light-chain amyloidosis

Risk stratification in cardiac amyloidosis: novel approaches

Skeletal scintigraphy indicates disease severity of cardiac involvement in patients with senile systemic amyloidosis

Staged heart transplantation and chemotherapy as a treatment option in patients with severe cardiac light-chain amyloidosis

The impact of allogeneic hematopoietic cell transplantation on the mortality of poor-risk non-Hodgkin lymphoma: an intent-to-transplant analysis

Translocation t(11;14) is associated with adverse outcome in patients with newly diagnosed AL amyloidosis when treated with bortezomib-based regimens

Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors

Treatment with intravenous melphalan and dexamethasone is not able to overcome the poor prognosis of patients with newly diagnosed systemic light chain amyloidosis and severe cardiac involvement